Cancer Stem Cells Market - Forecast(2022 - 2027)

Report Code: HCR 64849 Report Format: PDF + Excel

Cancer Stem Cell Market Overview

Cancer Stem Cell Market size was estimated at $923.7 million in 2020, projected to grow at a CAGR of 8.7% during the forecast period 2021-2026. Cancer Stem Cell industry is witnessing exponential growth owing to the rising number of clinical trials globally. Cancer Stem Cells (CSCs) represents a rare subset of cancer cells that express cell surface markers like CD24, CD44 and CD133. CSC has features like as ability to self-renew, differentiate in to a defined progenies, and initiates tumor growth in vivo. The formation of cancer is termed as carcinogenesis, where the normal cells are transformed to cancer cells. CSCs are tumorigenic and regenerates a tumor when transmitted to an animal host. Epithelial mesenchymal transition either inhibits or enhances CSCs in a cell type. Over past few years in regenerative medicine, Stem cells are used as especially useful in the field of dermatology. 

However, owing to the large number of ongoing pipeline projects for treatment of cancer, its application in oncology is predicted to experience higher growth rate. Cases of cancer is predicted to increase in a rapid pace. According to WHO, in the year 2018 around 18.1 million new cases were diagnosed and 9.6 million individuals died out of cancer. According to the Cancer research UK, the number of people diagnosed with cancer is predicted to rise in near future. By 2040, it is anticipated to reach 27.5 million new cases each year worldwide.

Cancer Stem Cell Market Report Coverage

The report: “Cancer Stem Cell Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer Stem Cell Market.
By Type of Cancer: Breast Cancer, Lung Cancer, Blood Cancer, Brain cancer, Liver Cancer, Bladder Cancer, Colorectal Cancer and Others.
By Application: Targeted Cancer Stem Cell and Stem cell based cancer therapy.
By End User: Hospitals, Ambulatory Surgical Centers, Cell and Tissue banks, Biotech Companies, Research Institutes, Academic Institutes, Contract Research and Organizations.
By Geography: North America (U.S, Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America), and Rest of the World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Cancer Stem Cell Market held the largest revenue share of 42% in 2020 owing to the highest disposable income and growing geriatric population in this region.
  • According to WHO 2.26 million new cases of breast cancer was reported in the year 2020.
  • Increase in prevalence of breast cancer, growing medical tourism in various developing countries are the other factors boosting the market growth and provide lucrative growth opportunities for the global market expansion.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market is provided in the Cancer Stem Cell Market.

Cancer Stem Cell Market: Market Share (%) by Region, 2020

Cancer Stem Cell Market
For More Details on This Report - Request for Sample

Cancer Stem Cell Market Segment Analysis – By Type of Cancer:

Based on Type of Cancer, Cancer Stem Cell Market is segmented into Breast Cancer, Lung Cancer, Blood Cancer, Brain cancer, Liver Cancer, Bladder Cancer, Colorectal Cancer and Others. Breast cancer segment accounted for largest revenue market share in the year 2020 owing to the rising prevalence of breast cancer along with presence of large number of stem cell therapies for such cancer type. According to U.S. Breast Cancer Statistics, 1 in every 8 U.S. women develops invasive breast cancer in their life time. The carcinogenesis process is divided in to three stages such as initiation, promotion and progression.

The mechanism of breast carcinogenesis is caused by levels of estrogen, mutagenic metabolites and stimulation of tissue growth. All these process together cause initiation, promotion and progression of carcinogenesis. Cancer stem cells and epithelial mesenchymal transition are considered to as a dangerous duo in progression of breast cancer. Lung cancer segment is poised to grow with the fastest CAGR of 9.4% in the forecast period 2021-2026 owing to the ongoing developments and growing prevalence of lung malignancy globally by smoking and other habits. Lung carcinogenesis is a stepwise and a complicates process involving genetic mutations as well as epigenetic changes that tend to alter cellular process like differentiation, proliferation, invasion and metastasis. According to National Cancer Registry Programme, India, Lung cancer is one of the most common cancer in males in India.

Cancer Stem Cell Market Segment Analysis – By Application:

Based on Application, Cancer Stem Cell Market is segmented into Targeted Cancer Stem Cell and Stem cell based cancer therapy. Targeted Cancer Stem Cell is further segmented into, allogenic cell treatment and autologous cell treatment. Stem cell based cancer therapy segment is accounted for the largest revenue market share in 2020. This is mainly attributed owing to the usage of stem cells to repair human tissues after chemotherapy. This is providing a significant opportunity to the growth of the segment. 

Growing research on biology of CSCs and their signalling pathways, and surface markers are enabling the development of agents. Targeted Cancer Stem Cells segment is poised to grow with the fastest CAGR of 9.2% in the forecast period 2021-2026. The diagnose of prostate cancer stem cells allows a powerful tool to investigate the tumorigenic process and helps in developing therapies targeted to the stem cell. The factors such as affordability, rising transplantation procedures improved survival rate are driving the market for this segment.

Cancer Stem Cell Market Segment Analysis – By Geography:

Based on Geography, North America Cancer Stem Cell Market accounted for the 42% revenue share in 2020. This mainly attribute to the presence of significant number of organizations that are engages in conducting research and development related to stem cell therapy. Moreover, this region constitutes several internationally recognized hospitals and medical institutes like as Cancer Treatment Center of America that offers stem cell therapies. 

Furthermore, according to breast cancer organization, U.S is estimated to have 281,550 new breast cancer cases in 2021 among U.S. women and breast cancer is considered as the most common cancer diagnosed in U.S. women. Asia-Pacific market is poised to grow with the fastest CAGR in the forecast period 2021-2026 owing its rising prevalence of Cancer, increasing health care expenditure coupled with advancements in healthcare infrastructure. According to National Cancer Registry Program, India, the patients with cancer in India is estimated to be 679,421 males and 712,758 females in 2020. 1 in every 68 males and 1 in every 29 females develop cancer during their lifetime.

Cancer Stem Cell Market Segment Analysis-Drivers

Increasing prevalence of Cancer:

According to WHO Cancer is considered as a leading cause of death globally and in 2020 it is reported that nearly 10 million deaths were caused by cancer. Breast, colorectal cancer, prostate, skin, stomach and lung cancer are some of the most common cancers according to World Health Organization (WHO). The rising number of cancer cases along with increasing patient awareness on cancer are the major factors driving the market growth. According to National Center for Disease Informatics and Research (NCDIR), and Indian Council of Medical Research (ICMR), Bangalore confirms increase in India’s cancer cases, and it is projected to rise by 12% in next five years. 

Moreover, enormous efforts by the government and the global health organizations like WHO and Center of Disease Control to create awareness among the people regarding cancer, and reduce the disease burden is predicted to favor the Cancer Stem Cells market expansion. For example, WHO collaborated with the International Agency for Research on Cancer (IARC) and some other UN organizations in order to control the prevalence of non-communicable Diseases.

Lack of Awareness in Emerging Economies:

Lack of awareness on cancer among people in emerging countries is poised to hinder the growth of the Cancer Stem Cells Market. In the developing countries especially larger population countries like China, India, Brazil, South Africa it has become very difficult to reach the rural people to provide healthcare facilities, as there is a lack of proper healthcare infrastructure and skilled technicians and medical professionals.

Cancer Stem Cell Market Segment Landscape:

Product launches, joint ventures, mergers and acquisitions, and geographical expansions are key strategies adopted by players in the Cancer Stem Cell Market. Cancer Stem Cell Market top 10 companies are AbbVie, Inc., Thermo Fisher Scientific, Inc., Lonza Stemline Therapeutics, Inc., Merck KGaA Bionomics, Miltenyi Biotec, MacroGenics, Inc., Irvine Scientific, STEMCELL technologies, Inc., Oncomed Pharmaceuticals., BIOTIME, Inc., Sino Biological Inc.

Acquisitions/Product Launches:

  • In April 2021, Thermo Fisher has announced to expand its Pharms service business with $17.4 billion PPD acquisition.

Related Reports:

Report Code: HCR 1226

Report Code: HCR 0195

For more Lifesciences and Healthcare Market reports, please click here

1. Cancer Stem Cell Market - Overview
    1.1 Definitions and Scope
2. Cancer Stem Cell Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type of Cancer
    2.3 Key trends by Application
    2.4 Key trends by End User
    2.5 Key trends by Geography
3. Cancer Stem Cell Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split - Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis – Average Selling Price
4. Cancer Stem Cell Market - Startup Companies Scenario Premium
        4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Cancer Stem Cell Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Cancer Stem Cell Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Cancer Stem Cell Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Cancer Stem Cell Market – By Type of Cancer (Market Size –$Million/$Billion)
    8.1 Breast Cancer
    8.2 Lung Cancer
    8.3 Blood Cancer
    8.4 Brain Cancer
    8.5 Liver Cancer
    8.6 Bladder Cancer
    8.7 Colorectal Cancer
    8.8 others
9. Cancer Stem Cell Market – By Application (Market Size –$Million/$Billion)
    9.1 Targeted Cancer Stem Cell
    9.2 Stem Cell based Cancer Therapy
10. Cancer Stem Cell Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Ambulatory Surgical Centers
    10.3 Cell & Tissue banks
    10.4 Biotech Companies
    10.5 Research Institutes
    10.6 Academic Institutes
    10.7 Contract Research Organizations
11. Cancer Stem Cell Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Cancer Stem Cell Market - Entropy
13. Cancer Stem Cell Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Cancer Stem Cell Market – Key Company List by Country Premium Premium
15. Cancer Stem Cell Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape Market 2019-2024 ($M)
1.1 List Of Companies Market 2019-2024 ($M) - Global Industry Research
1.2 Market Participation Categorization Market 2019-2024 ($M) - Global Industry Research
2.Global Competitive Landscape Market 2019-2024 (Volume/Units)
2.1 List Of Companies Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Market Participation Categorization Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Competitive Landscape Market 2019-2024 ($M)
3.1 List Of Companies Market 2019-2024 ($M) - Regional Industry Research
3.2 Market Participation Categorization Market 2019-2024 ($M) - Regional Industry Research
4.South America Competitive Landscape Market 2019-2024 ($M)
4.1 List Of Companies Market 2019-2024 ($M) - Regional Industry Research
4.2 Market Participation Categorization Market 2019-2024 ($M) - Regional Industry Research
5.Europe Competitive Landscape Market 2019-2024 ($M)
5.1 List Of Companies Market 2019-2024 ($M) - Regional Industry Research
5.2 Market Participation Categorization Market 2019-2024 ($M) - Regional Industry Research
6.APAC Competitive Landscape Market 2019-2024 ($M)
6.1 List Of Companies Market 2019-2024 ($M) - Regional Industry Research
6.2 Market Participation Categorization Market 2019-2024 ($M) - Regional Industry Research
7.MENA Competitive Landscape Market 2019-2024 ($M)
7.1 List Of Companies Market 2019-2024 ($M) - Regional Industry Research
7.2 Market Participation Categorization Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Cancer Stem Cells Market Revenue, 2019-2024 ($M)
2.Canada Cancer Stem Cells Market Revenue, 2019-2024 ($M)
3.Mexico Cancer Stem Cells Market Revenue, 2019-2024 ($M)
4.Brazil Cancer Stem Cells Market Revenue, 2019-2024 ($M)
5.Argentina Cancer Stem Cells Market Revenue, 2019-2024 ($M)
6.Peru Cancer Stem Cells Market Revenue, 2019-2024 ($M)
7.Colombia Cancer Stem Cells Market Revenue, 2019-2024 ($M)
8.Chile Cancer Stem Cells Market Revenue, 2019-2024 ($M)
9.Rest of South America Cancer Stem Cells Market Revenue, 2019-2024 ($M)
10.UK Cancer Stem Cells Market Revenue, 2019-2024 ($M)
11.Germany Cancer Stem Cells Market Revenue, 2019-2024 ($M)
12.France Cancer Stem Cells Market Revenue, 2019-2024 ($M)
13.Italy Cancer Stem Cells Market Revenue, 2019-2024 ($M)
14.Spain Cancer Stem Cells Market Revenue, 2019-2024 ($M)
15.Rest of Europe Cancer Stem Cells Market Revenue, 2019-2024 ($M)
16.China Cancer Stem Cells Market Revenue, 2019-2024 ($M)
17.India Cancer Stem Cells Market Revenue, 2019-2024 ($M)
18.Japan Cancer Stem Cells Market Revenue, 2019-2024 ($M)
19.South Korea Cancer Stem Cells Market Revenue, 2019-2024 ($M)
20.South Africa Cancer Stem Cells Market Revenue, 2019-2024 ($M)
21.North America Cancer Stem Cells By Application
22.South America Cancer Stem Cells By Application
23.Europe Cancer Stem Cells By Application
24.APAC Cancer Stem Cells By Application
25.MENA Cancer Stem Cells By Application